CIK 0001022079 · Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161387862
- Phone
- 9735202700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,730,307
- in 5 filings, $16.7M under 10b5-1 plans
Net −$16,730,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
- PFEIFFER GARY M −$292K Director sold 4% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-23 | SAMAD SAM Executive Vice President & CFO | Grant or award · Non-Qualifed Stock Option (right to buy) | +18,616 | 18,616 | ||
| 2023-02-23 | PREVOZNIK MICHAEL E SVP & General Counsel | Shares withheld for taxes | −811 | $147.86 | $120K | 38,413 |
| 2023-02-23 | PREVOZNIK MICHAEL E SVP & General Counsel | Grant or award | +2,442 | 40,855 | ||
| 2023-02-23 | PREVOZNIK MICHAEL E SVP & General Counsel | Grant or award · Non-Qualifed Stock Option (right to buy) | +9,653 | 9,653 | ||
| 2023-02-23 | Plewman Patrick SVP for Diagnostic Services | Shares withheld for taxes | −245 | $147.86 | $36K | 8,737 |
| 2023-02-23 | Plewman Patrick SVP for Diagnostic Services | Grant or award | +1,919 | 10,656 | ||
| 2023-02-23 | Plewman Patrick SVP for Diagnostic Services | Grant or award · Non-Qualifed Stock Option (right to buy) | +7,584 | 7,584 | ||
| 2023-02-23 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Shares withheld for taxes | −188 | $147.86 | $28K | 31,825 |
| 2023-02-23 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Grant or award | +498 | 32,328 | ||
| 2023-02-23 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Grant or award · Non-Qualifed Stock Option (right to buy) | +1,960 | 1,960 | ||
| 2023-02-23 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Shares withheld for taxes | −195 | $147.86 | $29K | 7,810 |
| 2023-02-23 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Grant or award | +2,094 | 9,904 | ||
| 2023-02-23 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Grant or award · Non-Qualifed Stock Option (right to buy) | +8,270 | 8,270 | ||
| 2023-02-23 | GARDNER MARK A SVP of Molecular Gen & Oncol | Grant or award | +1,919 | 2,921 | ||
| 2023-02-23 | GARDNER MARK A SVP of Molecular Gen & Oncol | Grant or award · Non-Qualifed Stock Option (right to buy) | +7,584 | 7,584 | ||
| 2023-02-23 | Doherty Catherine T. SVP, Regional Businesses | Shares withheld for taxes | −962 | $147.86 | $142K | 66,771 |
| 2023-02-23 | Doherty Catherine T. SVP, Regional Businesses | Grant or award | +3,838 | 70,609 | ||
| 2023-02-23 | DELANEY MARK E SVP & Chief Commercial Officer | Grant or award | +1,919 | 3,650 | ||
| 2023-02-23 | DELANEY MARK E SVP & Chief Commercial Officer | Grant or award · Non-Qualifed Stock Option (right to buy) | +7,584 | 7,584 | ||
| 2023-02-01 | Gregg Vicky B Director | Other acquisition | +64 | $146.75 | $9K | 17,130 |
Page 26 of 29 · 563 trades